Table 1.
56 patients with UCB N (%) | |
---|---|
Age (years) | |
<55 | 18 (32.2) |
55–69 | 12 (21.4) |
≥70 | 26 (46.4) |
Mean ± SD | 69.1 ± 12.6 |
Gender | |
Female | 20 (35.7) |
Male | 36 (64.3) |
Tumor stage | |
Non-muscle-invasive (Ta-T1) | 38 (67.8) |
Muscle-invasive (T2–T4) | 18 (32.2) |
Tumor grade | |
G1 | 13 (23.2) |
G2 | 29 (51.8) |
G3 | 14 (25.0) |
IHC expressiona | |
Low | 9 (16.1) |
Moderate | 22 (39.3) |
High | 25 (44.6) |
aPercentage of survivin (+) cells: low, 0–5%; moderate, 5–50%; high, >50%.